DNX Biopharmaceuticals Announces Collaboration with Lung Cancer Initiative at Johnson & Johnson BioTech February 19, 2020 DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident…
